Many US veterans of Afghanistan and Iraq have multiple physical and psychiatric problems. A major focus of research has been on determining the effects of mild Traumatic Brain Injury (mTBI), but mTBI is rarely diagnosed in the absence of co-occurring conditions such as blast exposure, post-traumatic stress disorder (PTSD), depression, substance abuse, etc. These potentially interactive psychological and physical conditions produce complex patterns of cognitive, psychological, and physical symptoms that impede civilian reintegration and complicate efficient and effective treatment planning. The Translational Research Center for TBI and Stress Disorders (TRACTS) has developed a multidisciplinary approach to the assessment of deployment trauma and its consequences in veterans of these wars. The prospective TRACTS longitudinal cohort study conducts state-of-the-art assessments in the domains of biomedical function, lifetime head trauma, psychological function encompassing deployment experience and lifetime exposure to traumatic events, neuropsychological function, and structural and functional neuroimaging. The TRACTS longitudinal cohort study is the first of its kind to comprehensively evaluate lifetime incidence of TBI and PTSD in these veterans, in addition to those incurred during military deployment. The protocol has begun to reveal information that will help improve understanding of the complex pathophysiology associated with co-occurring mTBI and related stress disorders.
are mild in severity. Post-traumatic stress disorder (PTSD) is also highly prevalent, occurring in 12-30% of service members and veterans returning from OEF/OIF/OND deployments (Hoge et al., 2004; Seal et al., 2009; Tanielian & Jaycox, 2008; Thomas et al., 2010) . It is generally understood that repeated deployments and high rates of blast exposures have contributed to the high prevalence rates of TBI, primarily mild TBI (mTBI), and PTSD.
Recent literature has also pointed to the high prevalence rate of co-existing mTBI and PTSD in OEF/OIF/OND veterans, which has led to a flurry of research investigating the interplay between the two conditions on a variety of outcome measures, including neurocognitive function and civilian reintegration (e.g. Bailie et al., 2016; French, Lange, & Brickell, 2014; Morissette et al., 2011; Soble, Spanierman, & Fitzgerald Smith, 2013; Storzbach et al., 2015; Verfaellie, Lafleche, Spiro, & Bousquet, 2014; Belanger, Kretzmer, Vanderploeg, & French, 2010; Vasterling et al., 2012) . While these lines of research have produced notable results across the spectrum of investigation, they necessarily fall short of a more thorough understanding of the factors influencing Veterans' mental and physical health because they have primarily focused on one or, at best, three co-existing conditions (e.g. mTBI, PTSD, depression). Tragically, many individual veterans of OEF/OIF/OND suffer from multiple physical and psychological problems related to their military service, often presenting with multiple and differing patterns and combinations that likely reflect the truly complex nature of deployment trauma (see Lippa et al., 2015) , individual personal history, genetic risk, and a myriad of other factors that influence individual resiliency.
Another major gap in the current literature is understanding how these deployment-related conditions influence individual veterans' health and function over the course of aging. The VA reported that about 73% of OEF/OIF/OND veterans utilizing VA health care were 46 years of age or younger, with 48.5% under the age of 27. At no time in our history have we had the opportunity to examine the effects of deployment trauma in such a young cohort with the opportunity to then track individual veterans as they age. Providing a detailed characterization of these veterans' physical and mental health within a few years of returning home, and then repeating this characterization at regular intervals, will allow us to determine which conditions or combinations of conditions are most detrimental to long-term functional outcome. This information will also allow us to identify profiles or phenotypes that are associated with poor outcomes so that we can identify individual veterans who are at high risk and possibly target interventions for these high-risk individuals to halt or thwart negative decline in the most cost effective way possible.
The sheer breadth of the potential moderating factors influencing functional outcome following military service requires a large-scale, prospective, longitudinal study using state-of-the-art tools to assess the entirety of an individual's clinical presentation. It is essential to examine medical/biological, environmental, and psychological risk factors in relation to neurocognitive and functional outcomes and to determine how those relationships evolve over time. The
Translational Research Center for TBI and Stress Disorders (TRACTS)
is a National Network Research Center (NRC) for TBI. A centerpiece of the TRACTS NRC is the longitudinal cohort study aimed to assess and track the potential effects of a lifetime of psychologically and/or physically traumatic experiences over time. The study is designed to conduct comprehensive assessments of all participants upon entry to the center (baseline), one to two years thence (Time 2), and then every five years thereafter (Time 3, …Time n).
The TRACTS methodological approach recognizes that the crux of the problem associated with deployment trauma is multi-morbidity; the facts are that military mTBI rarely occurs in isolation, and cooccurring TBI and PTSD are often co-morbid with a host of other medical conditions (e.g. metabolic disorders, mood disorders, anxiety disorders, sleep disorder, substance misuse, and chronic pain).
Like a geriatric population, young veterans of OEF/OIF/OND are burdened by multiple interacting conditions. Each on its own may have a negative effect, but cumulatively and over time, the impact upon veterans can be devastating to daily function.
The TRACTS approach to the assessment of veterans involves many unique features. First, we approach the assessment of trauma, both physical and psychological, across the lifetime continuum rather than as a snapshot in time that captures only military experiences. This is critically important because the effects of deployment on an individual do not play out independently of the context of his/her environmental and biological history. Thus, the assessment of head injury is accomplished using the Boston Assessment of Traumatic Brain Injury -Lifetime (BAT-L) and a lifetime approach to the administration of the Clinical Assessment of Post-traumatic Stress Disorder Scale (CAPS) (which is administered for three time epochs: pre-military, deployment, and worst time post-deployment).
Second, we assess for exposures to blast munitions with and without associated alterations of consciousness as a function of a veteran's estimated distance from blast. The distance has been shown to be a suitable proxy for blast intensity . Third, in addition to the trauma assessments, all participants complete an extensive battery of neuropsychological tests, selfreport measures of military experiences and deployments, high-resolution structural and functional magnatic resonance imaging (MRI), and a medical evaluation that includes samples for blood chemistry, genetics, and other analyses. Last, all participants, are asked to share their data with other investigators, which is accomplished via the TRACTS Data Repository so that the data are disseminated to other researchers.
The TRACTS longitudinal cohort study methods and general analyses for some of the medical, trauma history, and psychological information are presented later. This assessement is now completed for over 500 individuals, with data fully processed for the first 450 participants who comprise the current sample. The number of subjects in each individiual analysis varies slightly depending on factors such as participant tolerability of the tests and data integrity on any given measure/variable. We do not include here findings in the domains of genetics and methylation analysis Sadeh et al., 2015; Sadeh et al., 2016a Sadeh et al., , 2016b Wolf et al., 2016a; Wolf et al., 2016b) or neuroimaging (Lindemer, Salat, Leritz, McGlinchey, & Milberg, 2013; Maksimovskiy et al., 2014; Robinson et al., 2015; Trotter, Robinson, Milberg, McGlinchey, & Salat, 2015) , as the specific details involved in those studies are complex and too idiosycratic to be included in this more broad report.
| METHODS

| Participants
Participants were deployed or to-be-deployed service members of OEF/OIF/OND. Participants were recruited from the Greater Boston Metropolitan area, as well as throughout New England, via a full-time recruitment specialist who attended Yellow Ribbon Events, Task Force Meetings, and other events involving US Air National Guard, Marine and Marine Reserves, and Army and Army Reserve Units. Some participants also contacted our recruitment specialist in response to flyers posted in public areas of our VA medical center and by word of mouth of enrolled participants. In the process of recruitment, it was made clear to potential voluteers that our study focuses on understanding TBI, blast exposure and mental health issues as the result of military service. This strategy was intended to provide us with a sample enriched with these conditions so that we could statistically power critical comparisons and assess relationships among conditions in a more cost-efficient way than an unbiased, random sample. At the time of this report, we have characterized a sample of over 500 service members for a baseline evaluation, and over 250 of those 
| Inclusion criteria
The inclusionary criteria for enrollment into the TRACTS longitudinal cohort study were (and still are): age 18-65, service in OEF, OIF, or OND, or scheduled deployment.
| Exclusion criteria
The exclusionary criteria were (and still are): history of neurological illness other than TBI (such as Huntington's, Parkinson's, dementia, MS); history of seizures (not related to TBI); current diagnosis of schizophrenia spectrum or other psychotic disorders (not related to trauma); current diagnosis of bipolar or related disorders (not related to PTSD); current active suicidal and/or homicidal ideation, intent, or plan requiring crisis intervention; or cognitive disorder due to general medical condition other than TBI.
| General procedures
All procedures and the informed consent process were (and still are) monitored and approved by the Institutional Review Board of Human Studies Research at the VA Boston Healthcare System (VA BHS).
Participants were informed that the purpose of the research study is to better understand TBI and stress disorders in returning veterans from OEF/OIF/OND. All participants travel to TRACTS at the VA BHS to complete the evaluation lasting approximately eight to ten hours in the following domains (participants are reimbursed for the time and travel costs as indicated for each area of assessment): (1) biomedical, genomics, background and health data ($25), (2) TBI, trauma, and psychiatric assessment ($50), (3) neuropsycholgical and self-report indices ($50), and (4) 
| Biomedical data procedures
Cerebrovascular health was quantified via a number of biological and physiological measurements conducted by a medical technician. Participants completed a medical background questionnaire that assessed demographic and health history information. Biomedical data collection procedures included blood pressure, pulse, height, weight, waist-to-hip ratio, body mass index and blood draw (chemistry and genetics). Blood pressure was measured according to the American Heart Association guidelines (Pickering et al., 2005) . Two blood pressure and heart rate measurements were recorded in the standing and supine positions. 
| TBI, trauma, and psychiatric assessment
A doctoral-level psychologist conducted a clinical interview to assess TBI, trauma history, and psychiatric conditions. Each case was reviewed by at least three doctoral-level psychologists/psychiatrists to achieve a consensus diagnosis for TBI, PTSD, and other Axis I disorders. Interviews were recorded to assess interrater reliability. Interview time was not limited in any way and varied depending on number of head injuries, trauma history, and number of psychiatric diagnoses.
| Blast exposure and TBI assessment
The BAT-L semi-structured clinical interview was used to characterize blast exposures and assess and diagnose TBIs throughout the lifespan (pre-military, military, and post-military) . The BAT-L demonstrated strong correspondence with the Ohio State TBI Identification Method; OSU-TBI-ID (kappa =0.89; Kendall's tau-b = 0.95) and strong interrater reliability (kappa >0.80). The severity of TBIs was rated according to Department of Defense (DoD) criteria (see Table 1 ); mTBIs, or concussion, are further subdivided into grade I, II, or III injuries according to a hybrid classification system.
| Trauma assessment
The TRACTS approach to trauma assessment was similar to the lifetime approach used to capture TBI. First, the Traumatic Life Events Questionnaire (TLEQ; Kubany et al., 2000) was administered to identify traumatic stressors experienced. Subsequently, the TLEQ was reviewed with the participant by a psychologist, followed by the CAPS-IV (Blake et al., 1995) . The CAPS interview was performed to capture the presence and severity of PTSD for up to three time epochs if Criterion A events were reported: (1) current (past 30 days), (2) post-military deployment (the worst 30-day period after returning from deployment), and (3) pre-military (prior to active military service).
PTSD was diagnosed in accordance with DSM-IV criteria. PTSD severity was captured by a continuous CAPS total score (sum of the frequency and intensity ratings for symptom clusters B-C; ranges from 0 to 150).
CAPS-IV interrater reliability was examined in 5% of the cohort.
Audiotapes of 23 interviews were reviewed by independent raters and correspondence between the raters and the interviewer were compared. Interrater reliabilities were strong (kappa >0.68) for diagnoses for each time epoch (current and post-deployment). 
| Neuropsychological assessment
The neuropsychological test battery listed in Table 2 was designed to be administered at the baseline and subsequent follow-up assessments for all participants. This battery is not intended to be an exhaustive assessment of all neuropsychological functions. Neuropsychological impairments following mTBI, PTSD, and other comorbidities have been demonstrated primarily in the domains of attention, executive function, memory, and processing speed, and for this reason, these domains are examined more extensively.
| Self-report measures
A number of self-report measures were included in the battery to assess deployment experience, military to civilian transition, and to enhance the psychological evaluation. Participants completed each measure during his/her testing session. The complete list of measures is provided in Table 3 .
| Neuroimaging sequences
An aim of the TRACTS program is to understand the interaction of combat stress and head trauma on psychiatric and behavioral symptoms by examining neuroimaging markers of processes thought to underlie these dysfunctions. The imaging protocol is mentioned here, as it is a critical part of the TRACTS protocol; however, analyses of this rich dataset are beyond the scope of this report.
There are a number of published papers that describe the methodology in detail ( Traumatic Life Experience Questionnaire TLEQ Kubany et al., 2000 excluded the predeployment participants (n = 22, 5.1%), as their data are not reflective of the warzone deployment experience.
| Demographic and military characteristics of the TRACTS cohort
As can be seen in The majority of TRACTS veterans were exposed to at least one blast within 100 m (82%) ( Table 5 ). Most of the blast exposures reported were between 26 and 100 m (75%); however, almost half of the service members reported that they experienced a blast within 10 m (46%). The range of blast exposures estimated by service members was wide, ranging from 0 to 1102 blasts from <100 m.
| Traumatic brain injury (TBI)
More than two-thirds of TRACTS veterans reported a lifetime history TBI, 42% experienced one or more blast-related TBIs, 35% experienced a military TBI due to some other mechanism (e.g. blunt force trauma), and 23% of the sample experienced both types of injuries (multiple TBIs of which there was at least one TBI secondary to blast and one TBI secondary to another mechanism).
Thirty-one percent of veterans experienced a blast related mTBI, of which half (51%; n = 64) were mild grade I injuries indicating no loss of consciousness (LOC), and alteration of mental status (AMS) and/or post-traumatic amnesia (PTA) less than 15 minutes in duration (see Table 1 ). Fifty-four percent (n = 68) were mild grade II injuries indicating there was either an LOC associated with the event of less than five minutes duration or a PTA and/or AMS of >15 minutes. There were nine veterans (7%) with grade III blast-related mTBI (Table 5) . Nonblast related military TBIs (Military Other) were similarly split between grade I, II, and III injuries (Table 6 ). Military related injuries were thus all mild in severity and predominantly involved less than 15 minutes of AMS and LOC of less than five minutes.
Pre-deployment TBIs were prevalent in our sample. Almost half of veterans reported a TBI prior to enlistment (41%), and almost all of these were mild in severity. However, it is important to note that most of the moderate and all of the severe TBIs in our sample occurred prior to entry into military service. Following military discharge, 8% of veterans experienced a TBI (post-military TBIs). All but two of these were mild in severity (Table 6 ). 
| PTSD and psychiatric comorbidities
Almost two thirds of the TRACTS veterans (64%) had a diagnosis of current PTSD. Other current psychiatric conditions assessed by the SCID included depressive disorders (28%), anxiety disorders (not including PTSD) (21%), and substance abuse/dependence (16%) (Table 7) . Additionally, sleep disturbance was highly prevalent (79%) based on the Pittsburgh Sleep Quality Index (PSQI) self-report measure, as was current pain (71%), based on the McGill Short Form. More than half of our sample (58%) has three or more current psychiatric comorbidities (Table 7) . Prevalence rates of psychiatric and behavioral conditions among those with and without military TBI are provided. It is clear from these data that military TBI rarely occurs in isolation of co- 
| Self-report measures
The self-report measures revealed that veterans with military mTBI had more severe PTSD symptoms (PTSD Checklist), greater intensity of deployment-related combat and other war-zone experiences (DRRI), and greater severity of depression, anxiety, and stress symtoms (DASS) ( Schedule (WHODAS-II), was also significantly reduced in the mTBI group compared to the group without military mTBI based on the simple total score. The WHODAS-II complex total score was also calculated to provide us with qualitative information regarding TRACTS participants' level of disability relative to the general population (Üstün et al., 2010a) . Overall, the mean complex score revealed that 80.3% of the general population scored lower (less impairment) on the WHODAS-II than did TRACTS participants. Similarly to the simple scoring method, the complex total score was significantly higher (indicating greater impairment in functional status) in the mTBI group compared to the group without mTBI, and revealed that the mTBI group reported worse overall functioning than 84.6% of the population, whereas the group without mTBI reported worse functioning than 75.3% of the population.
| Biomedical characteristics
In the TRACTS cohort, body mass index (mean = 28.39, SD = 4.62) and LDL (mean = 114.18, SD = 33.46) were elevated above normal (Table 11) . Additionally, waist-to-hip ratio was significantly higher for those with mTBI compared to those without mTBI.
| DISCUSSION
The primary purpose of this report was to provide a description of the the work of Dr Wolf and her colleagues who are examing DNA methylation and how it influences epigenetic gene regulation in PTSD and other clinical conditions. Additional future plans for analyses include a longitudinal assessment of the effects of blast and mTBI (both singular and multiple exposures) over time. This important study will be able to speak directly to the issue of the effects of multiple TBI on brain health and function, and will provide critical information on the possible interaction between blast and mTBI exposure and aging (i.e. does either increase risk for dementia?).
The TRACTS longitudinal cohort study is the first of its kind to comprehensively examine data from neuropsychological, neuroimaging, and physiological sources in an OEF/OIF/OND veteran population. It is also the first study to retrospectively assess lifetime incidence of both mTBI and PTSD events, in addition to recent military traumatic events associated with current diagnoses. Indeed, the role of lifetime mTBI and PTSD is a central consideration in all examinations of the effects of deployment upon physical, emotional, cognitive, and functional outcome. Understanding the possible neurobiological and neuropsychiatric context that service members "bring to the table"
when sent off to war may help us to identify individuals who might be at heightened risk for poor outcomes following combat exposure.
Indeed, we have documented widespread changes in brain morphometry in veterans with PTSD who have a lifetime (childhood) history of psychological trauma (Corbo et al., 2014; Lindemer et al., 2013) . Thus, a greater understanding of lifetime context may help us to predict an individual's vunerablility to deployment trauma.
The prevalence of multiple psychiatric and behavioral conditions in individual TRACTS service members and veterans is alarming.
Pre-military TBI and multiple TBIs across the lifespan were highly prevalent. Exposure to multiple potentially psychologically traumatic events prior to military service was also highly prevalent. These data suggest that there should be an integrated screening process for mTBI and PTSD, given their high rate of co-occurrance and shared
symptoms. As we have demonstrated , separate screenings for each, even if both are eventually completed, may lead to misdiagnoses and inappropriate treatments.
Designing the TRACTS cohort study as a prospective longitudinal study affords tremendous advantages that would not be available given a cross-sectional design. Most importantly, this design enables investigators to examine how the presence of specific conditions and combinations of conditions affect individuals over time. Having first characterized each individual at a detailed level, and then repeating that assessment at periodic intervals, we allow us to examine how multiple factors (genetic, environmental, psychological, etc.) affect the progression of illnesses in this group over the course of aging, which will provide a window into how we might interrupt that progression. The longitudinal design also provides the study with the greatest statitstical power given its sample size by minimizing between-subject error.
The TRACTS sample is a convenience sample recruited by a fulltime recruitment specialist. The importance of the recruitment specialist to the success of this longitudinal study cannot be overstated. The OEF/OIF/OND cohort overall has been very difficult to engage clinically and typically has a high rate of appointment no-shows and cancellations. With the benefit of a full-time recruiter, TRACTS has been able to develop personal ties to each participant in order to keep them actively engaged in the program over time (some of our participants have now been enrolled for over seven years). TRACTS employs several other strategies to keep participants connected and committed to the study, including a bi-annual newsletter summarizing recent publications and onging research and rehabilitation opportunities, ongoing communication including appointment reminder letters as well as phone calls, and the ability to contact the study's recruiter directly by telephone with the knowledge that someone in the study is available to support them 24/7. We believe that in order for a longitudinal study such as TRACTS to be successful, it is necessary that participant engagement and commitment be high. This can only be achieved by high investigator engagement and commitment. Similarly, Esterman et al. (2013a) found that during a visual search task the presence of a task-irrelvant distractor disrupted search efficiency.
The disruption was correlated with both PTSD and depression severity, suggesting that PTSD and depression may involve a general alteration in salience-based and goal-directed attentional systems.
Combining behavioral and neuroimaging data, Lindemer et al. (2013) examined the relationship between PTSD and cortical thickness and its possible modification by mTBI. A clear negative relationship was observed between current PTSD severity and thickness, and this relationship was stronger and more extensive when looking at trauma in the context of an individual's lifetime rather than only their current symptoms. In addition, interactions between PTSD and comorbid mTBI were observed, implying an additive effect of the two comorbidities. A final example is a study by Lippa et al. (2015) , who conducted a factor analysis on many of the clinical and self-report measures in the TRACTS Data Repository and demonstrated how the various conditions tend to co-occur in individuals. Importantly, the study was the first to indicate that the combination of mTBI, PTSD, and depression was associated with substantial disability as measured by the WHODAS-II.
In sum, the current methodology represents an important evolution of research that has been designed to provide a more comprehensive understanding of the effects of deployment related trauma on physical and psychological health. Rather than studying a single burden or pathology, the TRACTS approach is to focus on the entirety of the individual who is actually impacted by these highly prevalent and comorbid conditions related to combat exposure. This approach will help determine how physical and psychological pathologies interact and are modulated by individual differences in biology, personality, and relevant experiences over the course of aging.
We anticipate that the findings generated from the TRACTS longitudinal cohort will make important contributions to this field of study and serve as a great resource to investigators studying OEF/OIF/OND veterans for many years to come.
| Limitations
There are some important limitations to consider with this methodology. First, information obtained regarding lifetimeTBI and PTSD events is remote (several months to years prior), making definitive diagnoses challenging. This is because these diagnoses are based on clinical interviews and self-report measures that can be influenced by individuals' memory for potential traumatic events. Similarly, assessment of deployment-related experiences may also be affected by memory loss associated with the time delay between return from deployment and the baseline assessment. Another important implication of this time delay is that symptoms may have stabilized over this time, which could limit our ability to track the progression of symtoms as they develop over time. Second, it is generally understood that there is considerable pressure on military service members and veterans to minimize difficulties out of concern for appearing "weak" or otherwise unable to perform their duties. This tendency may encourage an under-reporting of symptoms. Third, the TRACTS longitudinal cohort study is a convenience sample and, as such, has recruitment bias. During recruitment, veterans who report being in close proximity to blasts (less than 100 m) and/or who have history of military TBI are given priority in scheduling. This may be reflected in the higher number of Army and Marines, since they are most likely to have these kinds of exposures.
| Future directions
TRACTS will continue to recruit into the longitudinal cohort with the ultimate goal to maintain a baseline sample size of 750 and a longitudinal sample of 500. TRACTS has made some changes to the assessment battery to incorporate changes in diagnostic criteria from DSM-IV to DSM-5. However, to maintain the integrity of our longitudinal data, DSM-IV criteria have been continued, but we now incorporate necessary questions from the CAPS-5 to derive DSM-5 diagnosis and CAPS-5 severity scores. Likewise, we have incorporated necessary questions from the SCID-2 to derive DSM-5 diagnoses.
Additions to the self-report measures have enhanced our assessment of sensory changes following deployment, childhood trauma, binge pattern of alcohol consumption, and a more comprehensive assessment of functional status. Lastly, we have added a comprehensive eye examination to evaluate vision.
